Curaleaf Holdings (CURLF) Treasury Shares (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Treasury Shares of -$1.0 million for Q2 2024, up 79.84% year-over-year from -$583856.5 in Q3 2023, and down 200.0% quarter-over-quarter from $1.0 million in Q4 2023.
Curaleaf Holdings (CURLF) Treasury Shares (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Treasury Shares history runs 6 years deep, the most recent figure standing at -$1.0 million for Q2 2024.
- In Q2 2024, Treasury Shares rose 79.84% year-over-year to -$1.0 million; the TTM figure through Jun 2024 stood at -$1.0 million (up 79.84% YoY), while the FY2023 annual figure was $1.0 million, changed N/A from the prior year.
- Treasury Shares for Q2 2024 stood at -$1.0 million, down from $1.0 million in the prior quarter.
- The five-year high for Treasury Shares was $26.5 million in Q4 2025, with the low at $6.1 million in Q4 2023.
- The 3-year median for Treasury Shares is $6.3 million (2024), against an average of $13.0 million.
- Peak annual rise in Treasury Shares reached 200.0% in 2022, while the deepest fall reached 99900.0% in 2022.
- Curaleaf Holdings' Treasury Shares stood at $5.2 million in 2020, then slumped by 200.0% to -$5.2 million in 2021, then surged by 200.0% to $5.2 million in 2022, then tumbled by 79.84% to $1.0 million in 2023, then slumped by 200.0% to -$1.0 million in 2024.
- Business Quant data shows CURLF's Treasury Shares at -$1.0 million in Q2 2024, $1.0 million in Q4 2023, and -$5.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 19.00 Mn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.52 Mn |
| Jun 30, 2026 | 10.52 Mn |
| Dec 31, 2025 | 26.55 Mn |
| Dec 31, 2025 | 26.55 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 6.15 Mn |
| Dec 31, 2023 | 6.15 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Jun 30, 2023 | -5.21 Mn |
| Jun 30, 2023 | -5.21 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | -5.21 Mn |
| Sep 30, 2022 | -5.21 Mn |